nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP3A4—breast cancer	0.131	1	CbGaD
Aprepitant—CYP1A2—Anastrozole—breast cancer	0.0299	0.0571	CbGbCtD
Aprepitant—CYP1A2—Toremifene—breast cancer	0.0274	0.0522	CbGbCtD
Aprepitant—CYP2C9—Anastrozole—breast cancer	0.027	0.0515	CbGbCtD
Aprepitant—CYP3A5—Lapatinib—breast cancer	0.0268	0.0512	CbGbCtD
Aprepitant—CYP2C19—Lapatinib—breast cancer	0.0216	0.0413	CbGbCtD
Aprepitant—CYP3A4—Exemestane—breast cancer	0.0207	0.0395	CbGbCtD
Aprepitant—CYP2C9—Idarubicin—breast cancer	0.0204	0.039	CbGbCtD
Aprepitant—CYP3A7—Tamoxifen—breast cancer	0.0179	0.0342	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0179	0.0342	CbGbCtD
Aprepitant—CYP3A4—Letrozole—breast cancer	0.0176	0.0336	CbGbCtD
Aprepitant—CYP3A4—Anastrozole—breast cancer	0.0157	0.0299	CbGbCtD
Aprepitant—CYP3A4—Toremifene—breast cancer	0.0143	0.0274	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0139	0.0266	CbGbCtD
Aprepitant—CYP3A7—Paclitaxel—breast cancer	0.0139	0.0266	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.0138	0.0262	CbGbCtD
Aprepitant—CYP3A7—Irinotecan—breast cancer	0.0138	0.0262	CbGbCtD
Aprepitant—CYP3A5—Tamoxifen—breast cancer	0.0134	0.0256	CbGbCtD
Aprepitant—CYP3A4—Fulvestrant—breast cancer	0.0133	0.0254	CbGbCtD
Aprepitant—CYP3A4—Thiotepa—breast cancer	0.0119	0.0227	CbGbCtD
Aprepitant—CYP2C9—Capecitabine—breast cancer	0.0112	0.0214	CbGbCtD
Aprepitant—CYP3A4—Ixabepilone—breast cancer	0.0109	0.0207	CbGbCtD
Aprepitant—CYP2C19—Tamoxifen—breast cancer	0.0108	0.0207	CbGbCtD
Aprepitant—CYP3A4—Lapatinib—breast cancer	0.0105	0.02	CbGbCtD
Aprepitant—CYP3A5—Paclitaxel—breast cancer	0.0105	0.02	CbGbCtD
Aprepitant—CYP3A5—Irinotecan—breast cancer	0.0103	0.0197	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.0101	0.0192	CbGbCtD
Aprepitant—CYP3A7—Docetaxel—breast cancer	0.0101	0.0192	CbGbCtD
Aprepitant—CYP1A2—Tamoxifen—breast cancer	0.01	0.0191	CbGbCtD
Aprepitant—CYP2C9—Tamoxifen—breast cancer	0.00901	0.0172	CbGbCtD
Aprepitant—CYP3A4—Raloxifene—breast cancer	0.00793	0.0151	CbGbCtD
Aprepitant—CYP3A5—Docetaxel—breast cancer	0.00756	0.0144	CbGbCtD
Aprepitant—CYP1A2—Fluorouracil—breast cancer	0.00737	0.0141	CbGbCtD
Aprepitant—CYP2C9—Paclitaxel—breast cancer	0.00701	0.0134	CbGbCtD
Aprepitant—CYP2C9—Fluorouracil—breast cancer	0.00664	0.0127	CbGbCtD
Aprepitant—CYP3A4—Vinorelbine—breast cancer	0.0058	0.0111	CbGbCtD
Aprepitant—CYP3A4—Tamoxifen—breast cancer	0.00524	0.01	CbGbCtD
Aprepitant—CYP3A4—Mitoxantrone—breast cancer	0.00511	0.00975	CbGbCtD
Aprepitant—CYP3A4—Paclitaxel—breast cancer	0.00408	0.00778	CbGbCtD
Aprepitant—CYP3A4—Irinotecan—breast cancer	0.00402	0.00768	CbGbCtD
Aprepitant—CYP3A4—Vinblastine—breast cancer	0.00358	0.00682	CbGbCtD
Aprepitant—CYP3A4—Docetaxel—breast cancer	0.00295	0.00563	CbGbCtD
Aprepitant—CYP3A4—Doxorubicin—breast cancer	0.0022	0.00419	CbGbCtD
Aprepitant—Vomiting—Fluorouracil—breast cancer	3.15e-05	0.000133	CcSEcCtD
Aprepitant—Dyspepsia—Docetaxel—breast cancer	3.15e-05	0.000133	CcSEcCtD
Aprepitant—Insomnia—Capecitabine—breast cancer	3.14e-05	0.000132	CcSEcCtD
Aprepitant—Hypoaesthesia—Doxorubicin—breast cancer	3.13e-05	0.000132	CcSEcCtD
Aprepitant—Rash—Fluorouracil—breast cancer	3.13e-05	0.000132	CcSEcCtD
Aprepitant—Dermatitis—Fluorouracil—breast cancer	3.13e-05	0.000132	CcSEcCtD
Aprepitant—Pharyngitis—Doxorubicin—breast cancer	3.12e-05	0.000132	CcSEcCtD
Aprepitant—Paraesthesia—Capecitabine—breast cancer	3.11e-05	0.000131	CcSEcCtD
Aprepitant—Decreased appetite—Docetaxel—breast cancer	3.11e-05	0.000131	CcSEcCtD
Aprepitant—Hypersensitivity—Paclitaxel—breast cancer	3.11e-05	0.000131	CcSEcCtD
Aprepitant—Headache—Fluorouracil—breast cancer	3.11e-05	0.000131	CcSEcCtD
Aprepitant—Urinary tract disorder—Doxorubicin—breast cancer	3.11e-05	0.000131	CcSEcCtD
Aprepitant—Dysgeusia—Methotrexate—breast cancer	3.1e-05	0.000131	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Docetaxel—breast cancer	3.09e-05	0.000131	CcSEcCtD
Aprepitant—Connective tissue disorder—Doxorubicin—breast cancer	3.09e-05	0.000131	CcSEcCtD
Aprepitant—Dyspnoea—Capecitabine—breast cancer	3.09e-05	0.000131	CcSEcCtD
Aprepitant—Fatigue—Docetaxel—breast cancer	3.09e-05	0.00013	CcSEcCtD
Aprepitant—Angiopathy—Epirubicin—breast cancer	3.08e-05	0.00013	CcSEcCtD
Aprepitant—Urethral disorder—Doxorubicin—breast cancer	3.08e-05	0.00013	CcSEcCtD
Aprepitant—Nausea—Irinotecan—breast cancer	3.08e-05	0.00013	CcSEcCtD
Aprepitant—Nausea—Mitoxantrone—breast cancer	3.08e-05	0.00013	CcSEcCtD
Aprepitant—Immune system disorder—Epirubicin—breast cancer	3.07e-05	0.00013	CcSEcCtD
Aprepitant—Mediastinal disorder—Epirubicin—breast cancer	3.06e-05	0.000129	CcSEcCtD
Aprepitant—Constipation—Docetaxel—breast cancer	3.06e-05	0.000129	CcSEcCtD
Aprepitant—Pain—Docetaxel—breast cancer	3.06e-05	0.000129	CcSEcCtD
Aprepitant—Back pain—Methotrexate—breast cancer	3.06e-05	0.000129	CcSEcCtD
Aprepitant—Dyspepsia—Capecitabine—breast cancer	3.05e-05	0.000129	CcSEcCtD
Aprepitant—Chills—Epirubicin—breast cancer	3.05e-05	0.000129	CcSEcCtD
Aprepitant—Asthenia—Paclitaxel—breast cancer	3.03e-05	0.000128	CcSEcCtD
Aprepitant—Decreased appetite—Capecitabine—breast cancer	3.01e-05	0.000127	CcSEcCtD
Aprepitant—Alopecia—Epirubicin—breast cancer	3e-05	0.000127	CcSEcCtD
Aprepitant—Nausea—Gemcitabine—breast cancer	3e-05	0.000127	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Capecitabine—breast cancer	2.99e-05	0.000126	CcSEcCtD
Aprepitant—Fatigue—Capecitabine—breast cancer	2.99e-05	0.000126	CcSEcCtD
Aprepitant—Pruritus—Paclitaxel—breast cancer	2.99e-05	0.000126	CcSEcCtD
Aprepitant—Mental disorder—Epirubicin—breast cancer	2.98e-05	0.000126	CcSEcCtD
Aprepitant—Erythema multiforme—Doxorubicin—breast cancer	2.97e-05	0.000126	CcSEcCtD
Aprepitant—Pain—Capecitabine—breast cancer	2.97e-05	0.000125	CcSEcCtD
Aprepitant—Constipation—Capecitabine—breast cancer	2.97e-05	0.000125	CcSEcCtD
Aprepitant—Malnutrition—Epirubicin—breast cancer	2.96e-05	0.000125	CcSEcCtD
Aprepitant—Erythema—Epirubicin—breast cancer	2.96e-05	0.000125	CcSEcCtD
Aprepitant—Feeling abnormal—Docetaxel—breast cancer	2.95e-05	0.000125	CcSEcCtD
Aprepitant—Nausea—Fluorouracil—breast cancer	2.95e-05	0.000124	CcSEcCtD
Aprepitant—Eye disorder—Doxorubicin—breast cancer	2.94e-05	0.000124	CcSEcCtD
Aprepitant—Ill-defined disorder—Methotrexate—breast cancer	2.93e-05	0.000124	CcSEcCtD
Aprepitant—Tinnitus—Doxorubicin—breast cancer	2.93e-05	0.000124	CcSEcCtD
Aprepitant—Gastrointestinal pain—Docetaxel—breast cancer	2.93e-05	0.000124	CcSEcCtD
Aprepitant—Anaemia—Methotrexate—breast cancer	2.92e-05	0.000123	CcSEcCtD
Aprepitant—Cardiac disorder—Doxorubicin—breast cancer	2.92e-05	0.000123	CcSEcCtD
Aprepitant—Flushing—Doxorubicin—breast cancer	2.92e-05	0.000123	CcSEcCtD
Aprepitant—Flatulence—Epirubicin—breast cancer	2.92e-05	0.000123	CcSEcCtD
Aprepitant—Dysgeusia—Epirubicin—breast cancer	2.9e-05	0.000122	CcSEcCtD
Aprepitant—Diarrhoea—Paclitaxel—breast cancer	2.89e-05	0.000122	CcSEcCtD
Aprepitant—Back pain—Epirubicin—breast cancer	2.86e-05	0.000121	CcSEcCtD
Aprepitant—Feeling abnormal—Capecitabine—breast cancer	2.86e-05	0.000121	CcSEcCtD
Aprepitant—Angiopathy—Doxorubicin—breast cancer	2.85e-05	0.000121	CcSEcCtD
Aprepitant—Malaise—Methotrexate—breast cancer	2.85e-05	0.00012	CcSEcCtD
Aprepitant—Muscle spasms—Epirubicin—breast cancer	2.85e-05	0.00012	CcSEcCtD
Aprepitant—Immune system disorder—Doxorubicin—breast cancer	2.84e-05	0.00012	CcSEcCtD
Aprepitant—Gastrointestinal pain—Capecitabine—breast cancer	2.84e-05	0.00012	CcSEcCtD
Aprepitant—Mediastinal disorder—Doxorubicin—breast cancer	2.84e-05	0.00012	CcSEcCtD
Aprepitant—Abdominal pain—Docetaxel—breast cancer	2.83e-05	0.00012	CcSEcCtD
Aprepitant—Body temperature increased—Docetaxel—breast cancer	2.83e-05	0.00012	CcSEcCtD
Aprepitant—Chills—Doxorubicin—breast cancer	2.82e-05	0.000119	CcSEcCtD
Aprepitant—Dizziness—Paclitaxel—breast cancer	2.79e-05	0.000118	CcSEcCtD
Aprepitant—Alopecia—Doxorubicin—breast cancer	2.78e-05	0.000117	CcSEcCtD
Aprepitant—Cough—Methotrexate—breast cancer	2.76e-05	0.000117	CcSEcCtD
Aprepitant—Mental disorder—Doxorubicin—breast cancer	2.76e-05	0.000116	CcSEcCtD
Aprepitant—Urticaria—Capecitabine—breast cancer	2.75e-05	0.000116	CcSEcCtD
Aprepitant—Ill-defined disorder—Epirubicin—breast cancer	2.75e-05	0.000116	CcSEcCtD
Aprepitant—Body temperature increased—Capecitabine—breast cancer	2.74e-05	0.000116	CcSEcCtD
Aprepitant—Abdominal pain—Capecitabine—breast cancer	2.74e-05	0.000116	CcSEcCtD
Aprepitant—Convulsion—Methotrexate—breast cancer	2.74e-05	0.000116	CcSEcCtD
Aprepitant—Erythema—Doxorubicin—breast cancer	2.74e-05	0.000116	CcSEcCtD
Aprepitant—Malnutrition—Doxorubicin—breast cancer	2.74e-05	0.000116	CcSEcCtD
Aprepitant—Anaemia—Epirubicin—breast cancer	2.74e-05	0.000116	CcSEcCtD
Aprepitant—Flatulence—Doxorubicin—breast cancer	2.7e-05	0.000114	CcSEcCtD
Aprepitant—Chest pain—Methotrexate—breast cancer	2.69e-05	0.000114	CcSEcCtD
Aprepitant—Arthralgia—Methotrexate—breast cancer	2.69e-05	0.000114	CcSEcCtD
Aprepitant—Myalgia—Methotrexate—breast cancer	2.69e-05	0.000114	CcSEcCtD
Aprepitant—Vomiting—Paclitaxel—breast cancer	2.69e-05	0.000113	CcSEcCtD
Aprepitant—Dysgeusia—Doxorubicin—breast cancer	2.68e-05	0.000113	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.67e-05	0.000113	CcSEcCtD
Aprepitant—Malaise—Epirubicin—breast cancer	2.67e-05	0.000113	CcSEcCtD
Aprepitant—Rash—Paclitaxel—breast cancer	2.66e-05	0.000112	CcSEcCtD
Aprepitant—Dermatitis—Paclitaxel—breast cancer	2.66e-05	0.000112	CcSEcCtD
Aprepitant—Discomfort—Methotrexate—breast cancer	2.66e-05	0.000112	CcSEcCtD
Aprepitant—Syncope—Epirubicin—breast cancer	2.65e-05	0.000112	CcSEcCtD
Aprepitant—Back pain—Doxorubicin—breast cancer	2.65e-05	0.000112	CcSEcCtD
Aprepitant—Headache—Paclitaxel—breast cancer	2.65e-05	0.000112	CcSEcCtD
Aprepitant—Hypersensitivity—Docetaxel—breast cancer	2.64e-05	0.000111	CcSEcCtD
Aprepitant—Muscle spasms—Doxorubicin—breast cancer	2.63e-05	0.000111	CcSEcCtD
Aprepitant—Palpitations—Epirubicin—breast cancer	2.62e-05	0.00011	CcSEcCtD
Aprepitant—Confusional state—Methotrexate—breast cancer	2.6e-05	0.00011	CcSEcCtD
Aprepitant—Loss of consciousness—Epirubicin—breast cancer	2.6e-05	0.00011	CcSEcCtD
Aprepitant—Cough—Epirubicin—breast cancer	2.58e-05	0.000109	CcSEcCtD
Aprepitant—Anaphylactic shock—Methotrexate—breast cancer	2.58e-05	0.000109	CcSEcCtD
Aprepitant—Asthenia—Docetaxel—breast cancer	2.57e-05	0.000108	CcSEcCtD
Aprepitant—Convulsion—Epirubicin—breast cancer	2.56e-05	0.000108	CcSEcCtD
Aprepitant—Infection—Methotrexate—breast cancer	2.56e-05	0.000108	CcSEcCtD
Aprepitant—Hypertension—Epirubicin—breast cancer	2.56e-05	0.000108	CcSEcCtD
Aprepitant—Hypersensitivity—Capecitabine—breast cancer	2.55e-05	0.000108	CcSEcCtD
Aprepitant—Ill-defined disorder—Doxorubicin—breast cancer	2.54e-05	0.000107	CcSEcCtD
Aprepitant—Pruritus—Docetaxel—breast cancer	2.53e-05	0.000107	CcSEcCtD
Aprepitant—Nervous system disorder—Methotrexate—breast cancer	2.53e-05	0.000107	CcSEcCtD
Aprepitant—Anaemia—Doxorubicin—breast cancer	2.53e-05	0.000107	CcSEcCtD
Aprepitant—Thrombocytopenia—Methotrexate—breast cancer	2.53e-05	0.000107	CcSEcCtD
Aprepitant—Myalgia—Epirubicin—breast cancer	2.52e-05	0.000106	CcSEcCtD
Aprepitant—Chest pain—Epirubicin—breast cancer	2.52e-05	0.000106	CcSEcCtD
Aprepitant—Arthralgia—Epirubicin—breast cancer	2.52e-05	0.000106	CcSEcCtD
Aprepitant—Anxiety—Epirubicin—breast cancer	2.51e-05	0.000106	CcSEcCtD
Aprepitant—Nausea—Paclitaxel—breast cancer	2.51e-05	0.000106	CcSEcCtD
Aprepitant—Skin disorder—Methotrexate—breast cancer	2.51e-05	0.000106	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.5e-05	0.000106	CcSEcCtD
Aprepitant—Hyperhidrosis—Methotrexate—breast cancer	2.5e-05	0.000105	CcSEcCtD
Aprepitant—Discomfort—Epirubicin—breast cancer	2.49e-05	0.000105	CcSEcCtD
Aprepitant—Asthenia—Capecitabine—breast cancer	2.49e-05	0.000105	CcSEcCtD
Aprepitant—Malaise—Doxorubicin—breast cancer	2.47e-05	0.000104	CcSEcCtD
Aprepitant—Dry mouth—Epirubicin—breast cancer	2.46e-05	0.000104	CcSEcCtD
Aprepitant—Anorexia—Methotrexate—breast cancer	2.46e-05	0.000104	CcSEcCtD
Aprepitant—Syncope—Doxorubicin—breast cancer	2.46e-05	0.000104	CcSEcCtD
Aprepitant—Pruritus—Capecitabine—breast cancer	2.45e-05	0.000104	CcSEcCtD
Aprepitant—Diarrhoea—Docetaxel—breast cancer	2.45e-05	0.000103	CcSEcCtD
Aprepitant—Confusional state—Epirubicin—breast cancer	2.44e-05	0.000103	CcSEcCtD
Aprepitant—Palpitations—Doxorubicin—breast cancer	2.42e-05	0.000102	CcSEcCtD
Aprepitant—Anaphylactic shock—Epirubicin—breast cancer	2.42e-05	0.000102	CcSEcCtD
Aprepitant—Oedema—Epirubicin—breast cancer	2.42e-05	0.000102	CcSEcCtD
Aprepitant—Hypotension—Methotrexate—breast cancer	2.41e-05	0.000102	CcSEcCtD
Aprepitant—Loss of consciousness—Doxorubicin—breast cancer	2.41e-05	0.000102	CcSEcCtD
Aprepitant—Infection—Epirubicin—breast cancer	2.4e-05	0.000101	CcSEcCtD
Aprepitant—Cough—Doxorubicin—breast cancer	2.39e-05	0.000101	CcSEcCtD
Aprepitant—Shock—Epirubicin—breast cancer	2.38e-05	0.0001	CcSEcCtD
Aprepitant—Convulsion—Doxorubicin—breast cancer	2.37e-05	0.0001	CcSEcCtD
Aprepitant—Diarrhoea—Capecitabine—breast cancer	2.37e-05	0.0001	CcSEcCtD
Aprepitant—Nervous system disorder—Epirubicin—breast cancer	2.37e-05	0.0001	CcSEcCtD
Aprepitant—Dizziness—Docetaxel—breast cancer	2.37e-05	0.0001	CcSEcCtD
Aprepitant—Thrombocytopenia—Epirubicin—breast cancer	2.37e-05	9.99e-05	CcSEcCtD
Aprepitant—Hypertension—Doxorubicin—breast cancer	2.36e-05	9.98e-05	CcSEcCtD
Aprepitant—Tachycardia—Epirubicin—breast cancer	2.36e-05	9.95e-05	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methotrexate—breast cancer	2.35e-05	9.93e-05	CcSEcCtD
Aprepitant—Skin disorder—Epirubicin—breast cancer	2.35e-05	9.91e-05	CcSEcCtD
Aprepitant—Hyperhidrosis—Epirubicin—breast cancer	2.34e-05	9.86e-05	CcSEcCtD
Aprepitant—Insomnia—Methotrexate—breast cancer	2.33e-05	9.86e-05	CcSEcCtD
Aprepitant—Myalgia—Doxorubicin—breast cancer	2.33e-05	9.84e-05	CcSEcCtD
Aprepitant—Arthralgia—Doxorubicin—breast cancer	2.33e-05	9.84e-05	CcSEcCtD
Aprepitant—Chest pain—Doxorubicin—breast cancer	2.33e-05	9.84e-05	CcSEcCtD
Aprepitant—Anxiety—Doxorubicin—breast cancer	2.32e-05	9.81e-05	CcSEcCtD
Aprepitant—Paraesthesia—Methotrexate—breast cancer	2.32e-05	9.79e-05	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.32e-05	9.78e-05	CcSEcCtD
Aprepitant—Discomfort—Doxorubicin—breast cancer	2.3e-05	9.73e-05	CcSEcCtD
Aprepitant—Anorexia—Epirubicin—breast cancer	2.3e-05	9.72e-05	CcSEcCtD
Aprepitant—Dyspnoea—Methotrexate—breast cancer	2.3e-05	9.72e-05	CcSEcCtD
Aprepitant—Somnolence—Methotrexate—breast cancer	2.29e-05	9.69e-05	CcSEcCtD
Aprepitant—Dizziness—Capecitabine—breast cancer	2.29e-05	9.68e-05	CcSEcCtD
Aprepitant—Dry mouth—Doxorubicin—breast cancer	2.28e-05	9.63e-05	CcSEcCtD
Aprepitant—Vomiting—Docetaxel—breast cancer	2.28e-05	9.61e-05	CcSEcCtD
Aprepitant—Dyspepsia—Methotrexate—breast cancer	2.27e-05	9.59e-05	CcSEcCtD
Aprepitant—Rash—Docetaxel—breast cancer	2.26e-05	9.53e-05	CcSEcCtD
Aprepitant—Hypotension—Epirubicin—breast cancer	2.26e-05	9.53e-05	CcSEcCtD
Aprepitant—Dermatitis—Docetaxel—breast cancer	2.26e-05	9.53e-05	CcSEcCtD
Aprepitant—Confusional state—Doxorubicin—breast cancer	2.25e-05	9.52e-05	CcSEcCtD
Aprepitant—Decreased appetite—Methotrexate—breast cancer	2.24e-05	9.47e-05	CcSEcCtD
Aprepitant—Headache—Docetaxel—breast cancer	2.24e-05	9.47e-05	CcSEcCtD
Aprepitant—Anaphylactic shock—Doxorubicin—breast cancer	2.24e-05	9.44e-05	CcSEcCtD
Aprepitant—Oedema—Doxorubicin—breast cancer	2.24e-05	9.44e-05	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Methotrexate—breast cancer	2.23e-05	9.41e-05	CcSEcCtD
Aprepitant—Fatigue—Methotrexate—breast cancer	2.23e-05	9.4e-05	CcSEcCtD
Aprepitant—Infection—Doxorubicin—breast cancer	2.22e-05	9.38e-05	CcSEcCtD
Aprepitant—Pain—Methotrexate—breast cancer	2.21e-05	9.32e-05	CcSEcCtD
Aprepitant—Vomiting—Capecitabine—breast cancer	2.2e-05	9.31e-05	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Epirubicin—breast cancer	2.2e-05	9.29e-05	CcSEcCtD
Aprepitant—Shock—Doxorubicin—breast cancer	2.2e-05	9.28e-05	CcSEcCtD
Aprepitant—Nervous system disorder—Doxorubicin—breast cancer	2.19e-05	9.25e-05	CcSEcCtD
Aprepitant—Thrombocytopenia—Doxorubicin—breast cancer	2.19e-05	9.24e-05	CcSEcCtD
Aprepitant—Rash—Capecitabine—breast cancer	2.19e-05	9.23e-05	CcSEcCtD
Aprepitant—Insomnia—Epirubicin—breast cancer	2.18e-05	9.22e-05	CcSEcCtD
Aprepitant—Dermatitis—Capecitabine—breast cancer	2.18e-05	9.22e-05	CcSEcCtD
Aprepitant—Tachycardia—Doxorubicin—breast cancer	2.18e-05	9.21e-05	CcSEcCtD
Aprepitant—Headache—Capecitabine—breast cancer	2.17e-05	9.17e-05	CcSEcCtD
Aprepitant—Skin disorder—Doxorubicin—breast cancer	2.17e-05	9.17e-05	CcSEcCtD
Aprepitant—Paraesthesia—Epirubicin—breast cancer	2.17e-05	9.16e-05	CcSEcCtD
Aprepitant—Hyperhidrosis—Doxorubicin—breast cancer	2.16e-05	9.12e-05	CcSEcCtD
Aprepitant—Dyspnoea—Epirubicin—breast cancer	2.15e-05	9.09e-05	CcSEcCtD
Aprepitant—Somnolence—Epirubicin—breast cancer	2.15e-05	9.07e-05	CcSEcCtD
Aprepitant—Anorexia—Doxorubicin—breast cancer	2.13e-05	9e-05	CcSEcCtD
Aprepitant—Nausea—Docetaxel—breast cancer	2.13e-05	8.98e-05	CcSEcCtD
Aprepitant—Feeling abnormal—Methotrexate—breast cancer	2.13e-05	8.98e-05	CcSEcCtD
Aprepitant—Dyspepsia—Epirubicin—breast cancer	2.13e-05	8.98e-05	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methotrexate—breast cancer	2.11e-05	8.91e-05	CcSEcCtD
Aprepitant—Decreased appetite—Epirubicin—breast cancer	2.1e-05	8.87e-05	CcSEcCtD
Aprepitant—Hypotension—Doxorubicin—breast cancer	2.09e-05	8.82e-05	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Epirubicin—breast cancer	2.09e-05	8.81e-05	CcSEcCtD
Aprepitant—Fatigue—Epirubicin—breast cancer	2.08e-05	8.79e-05	CcSEcCtD
Aprepitant—Pain—Epirubicin—breast cancer	2.07e-05	8.72e-05	CcSEcCtD
Aprepitant—Constipation—Epirubicin—breast cancer	2.07e-05	8.72e-05	CcSEcCtD
Aprepitant—Nausea—Capecitabine—breast cancer	2.06e-05	8.7e-05	CcSEcCtD
Aprepitant—Urticaria—Methotrexate—breast cancer	2.05e-05	8.66e-05	CcSEcCtD
Aprepitant—Abdominal pain—Methotrexate—breast cancer	2.04e-05	8.62e-05	CcSEcCtD
Aprepitant—Body temperature increased—Methotrexate—breast cancer	2.04e-05	8.62e-05	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.04e-05	8.6e-05	CcSEcCtD
Aprepitant—Insomnia—Doxorubicin—breast cancer	2.02e-05	8.54e-05	CcSEcCtD
Aprepitant—Paraesthesia—Doxorubicin—breast cancer	2.01e-05	8.47e-05	CcSEcCtD
Aprepitant—Dyspnoea—Doxorubicin—breast cancer	1.99e-05	8.41e-05	CcSEcCtD
Aprepitant—Feeling abnormal—Epirubicin—breast cancer	1.99e-05	8.4e-05	CcSEcCtD
Aprepitant—Somnolence—Doxorubicin—breast cancer	1.99e-05	8.39e-05	CcSEcCtD
Aprepitant—Gastrointestinal pain—Epirubicin—breast cancer	1.98e-05	8.34e-05	CcSEcCtD
Aprepitant—Dyspepsia—Doxorubicin—breast cancer	1.97e-05	8.31e-05	CcSEcCtD
Aprepitant—Decreased appetite—Doxorubicin—breast cancer	1.94e-05	8.2e-05	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Doxorubicin—breast cancer	1.93e-05	8.15e-05	CcSEcCtD
Aprepitant—Fatigue—Doxorubicin—breast cancer	1.93e-05	8.14e-05	CcSEcCtD
Aprepitant—Urticaria—Epirubicin—breast cancer	1.92e-05	8.1e-05	CcSEcCtD
Aprepitant—Pain—Doxorubicin—breast cancer	1.91e-05	8.07e-05	CcSEcCtD
Aprepitant—Constipation—Doxorubicin—breast cancer	1.91e-05	8.07e-05	CcSEcCtD
Aprepitant—Abdominal pain—Epirubicin—breast cancer	1.91e-05	8.06e-05	CcSEcCtD
Aprepitant—Body temperature increased—Epirubicin—breast cancer	1.91e-05	8.06e-05	CcSEcCtD
Aprepitant—Hypersensitivity—Methotrexate—breast cancer	1.9e-05	8.03e-05	CcSEcCtD
Aprepitant—Asthenia—Methotrexate—breast cancer	1.85e-05	7.82e-05	CcSEcCtD
Aprepitant—Feeling abnormal—Doxorubicin—breast cancer	1.84e-05	7.78e-05	CcSEcCtD
Aprepitant—Gastrointestinal pain—Doxorubicin—breast cancer	1.83e-05	7.72e-05	CcSEcCtD
Aprepitant—Pruritus—Methotrexate—breast cancer	1.83e-05	7.71e-05	CcSEcCtD
Aprepitant—Hypersensitivity—Epirubicin—breast cancer	1.78e-05	7.51e-05	CcSEcCtD
Aprepitant—Urticaria—Doxorubicin—breast cancer	1.78e-05	7.5e-05	CcSEcCtD
Aprepitant—Body temperature increased—Doxorubicin—breast cancer	1.77e-05	7.46e-05	CcSEcCtD
Aprepitant—Abdominal pain—Doxorubicin—breast cancer	1.77e-05	7.46e-05	CcSEcCtD
Aprepitant—Diarrhoea—Methotrexate—breast cancer	1.77e-05	7.46e-05	CcSEcCtD
Aprepitant—Asthenia—Epirubicin—breast cancer	1.73e-05	7.32e-05	CcSEcCtD
Aprepitant—Pruritus—Epirubicin—breast cancer	1.71e-05	7.22e-05	CcSEcCtD
Aprepitant—Dizziness—Methotrexate—breast cancer	1.71e-05	7.21e-05	CcSEcCtD
Aprepitant—Diarrhoea—Epirubicin—breast cancer	1.65e-05	6.98e-05	CcSEcCtD
Aprepitant—Hypersensitivity—Doxorubicin—breast cancer	1.65e-05	6.95e-05	CcSEcCtD
Aprepitant—Vomiting—Methotrexate—breast cancer	1.64e-05	6.93e-05	CcSEcCtD
Aprepitant—Rash—Methotrexate—breast cancer	1.63e-05	6.87e-05	CcSEcCtD
Aprepitant—Dermatitis—Methotrexate—breast cancer	1.63e-05	6.87e-05	CcSEcCtD
Aprepitant—Headache—Methotrexate—breast cancer	1.62e-05	6.83e-05	CcSEcCtD
Aprepitant—Asthenia—Doxorubicin—breast cancer	1.6e-05	6.77e-05	CcSEcCtD
Aprepitant—Dizziness—Epirubicin—breast cancer	1.6e-05	6.74e-05	CcSEcCtD
Aprepitant—Pruritus—Doxorubicin—breast cancer	1.58e-05	6.68e-05	CcSEcCtD
Aprepitant—Vomiting—Epirubicin—breast cancer	1.54e-05	6.48e-05	CcSEcCtD
Aprepitant—Nausea—Methotrexate—breast cancer	1.53e-05	6.47e-05	CcSEcCtD
Aprepitant—Diarrhoea—Doxorubicin—breast cancer	1.53e-05	6.46e-05	CcSEcCtD
Aprepitant—Rash—Epirubicin—breast cancer	1.52e-05	6.43e-05	CcSEcCtD
Aprepitant—Dermatitis—Epirubicin—breast cancer	1.52e-05	6.42e-05	CcSEcCtD
Aprepitant—Headache—Epirubicin—breast cancer	1.51e-05	6.39e-05	CcSEcCtD
Aprepitant—Dizziness—Doxorubicin—breast cancer	1.48e-05	6.24e-05	CcSEcCtD
Aprepitant—Nausea—Epirubicin—breast cancer	1.43e-05	6.06e-05	CcSEcCtD
Aprepitant—Vomiting—Doxorubicin—breast cancer	1.42e-05	6e-05	CcSEcCtD
Aprepitant—Rash—Doxorubicin—breast cancer	1.41e-05	5.95e-05	CcSEcCtD
Aprepitant—Dermatitis—Doxorubicin—breast cancer	1.41e-05	5.94e-05	CcSEcCtD
Aprepitant—Headache—Doxorubicin—breast cancer	1.4e-05	5.91e-05	CcSEcCtD
Aprepitant—Nausea—Doxorubicin—breast cancer	1.33e-05	5.61e-05	CcSEcCtD
Aprepitant—CYP2C9—Metabolism—HBA1—breast cancer	5.11e-06	4.71e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.1e-06	4.71e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CAV1—breast cancer	5.08e-06	4.68e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.04e-06	4.65e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CA—breast cancer	5.03e-06	4.64e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP2D6—breast cancer	5.02e-06	4.63e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCC1—breast cancer	4.98e-06	4.6e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTA3—breast cancer	4.98e-06	4.6e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMMR—breast cancer	4.98e-06	4.6e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ACHE—breast cancer	4.98e-06	4.6e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTT1—breast cancer	4.98e-06	4.6e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.96e-06	4.58e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NCOA2—breast cancer	4.93e-06	4.55e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—COMT—breast cancer	4.92e-06	4.54e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTP1—breast cancer	4.9e-06	4.52e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—breast cancer	4.87e-06	4.49e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HMOX1—breast cancer	4.83e-06	4.46e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.83e-06	4.45e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ITPR1—breast cancer	4.82e-06	4.45e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MED12—breast cancer	4.82e-06	4.44e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—DPYD—breast cancer	4.82e-06	4.44e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—FASN—breast cancer	4.78e-06	4.41e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—BCHE—breast cancer	4.76e-06	4.39e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALDOA—breast cancer	4.74e-06	4.37e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP17A1—breast cancer	4.72e-06	4.35e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC5A5—breast cancer	4.7e-06	4.34e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS1—breast cancer	4.67e-06	4.31e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ENO1—breast cancer	4.67e-06	4.31e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HRAS—breast cancer	4.66e-06	4.3e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.65e-06	4.29e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCB1—breast cancer	4.64e-06	4.28e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CG—breast cancer	4.63e-06	4.27e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NCOA3—breast cancer	4.6e-06	4.25e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.59e-06	4.24e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2D6—breast cancer	4.58e-06	4.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC2A2—breast cancer	4.57e-06	4.22e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTA4—breast cancer	4.56e-06	4.21e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA9—breast cancer	4.56e-06	4.21e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TYMS—breast cancer	4.56e-06	4.2e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NQO1—breast cancer	4.54e-06	4.19e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC2A1—breast cancer	4.54e-06	4.19e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.52e-06	4.17e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTM1—breast cancer	4.5e-06	4.15e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NCOR1—breast cancer	4.5e-06	4.15e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PLA2G4A—breast cancer	4.5e-06	4.15e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NCOA2—breast cancer	4.49e-06	4.15e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CPT1A—breast cancer	4.48e-06	4.13e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTR—breast cancer	4.48e-06	4.13e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCG2—breast cancer	4.48e-06	4.13e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—breast cancer	4.46e-06	4.11e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.45e-06	4.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTA2—breast cancer	4.44e-06	4.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX2—breast cancer	4.44e-06	4.1e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP3A4—breast cancer	4.43e-06	4.09e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.41e-06	4.07e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HPGDS—breast cancer	4.39e-06	4.05e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX4—breast cancer	4.39e-06	4.05e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SULT1A1—breast cancer	4.39e-06	4.05e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HBA1—breast cancer	4.36e-06	4.03e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—FASN—breast cancer	4.36e-06	4.02e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP1B1—breast cancer	4.35e-06	4.02e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—BCHE—breast cancer	4.34e-06	4e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GPX1—breast cancer	4.31e-06	3.98e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC5A5—breast cancer	4.29e-06	3.96e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—IDH1—breast cancer	4.29e-06	3.95e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTA1—breast cancer	4.29e-06	3.95e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HSP90AA1—breast cancer	4.27e-06	3.94e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP1A1—breast cancer	4.27e-06	3.94e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTT1—breast cancer	4.26e-06	3.93e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ACHE—breast cancer	4.26e-06	3.93e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NAT2—breast cancer	4.24e-06	3.91e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ERCC2—breast cancer	4.23e-06	3.91e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NCOA1—breast cancer	4.15e-06	3.83e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC2A1—breast cancer	4.14e-06	3.82e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NQO1—breast cancer	4.14e-06	3.82e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT1—breast cancer	4.11e-06	3.79e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—STK11—breast cancer	4.09e-06	3.78e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP19A1—breast cancer	4.09e-06	3.78e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CD—breast cancer	4.07e-06	3.75e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.06e-06	3.74e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP3A4—breast cancer	4.04e-06	3.73e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP17A1—breast cancer	4.03e-06	3.72e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.02e-06	3.71e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—breast cancer	4.01e-06	3.7e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ENO1—breast cancer	3.99e-06	3.68e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS1—breast cancer	3.99e-06	3.68e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—breast cancer	3.98e-06	3.67e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.98e-06	3.67e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP1B1—breast cancer	3.97e-06	3.66e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.92e-06	3.62e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2D6—breast cancer	3.91e-06	3.61e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.89e-06	3.59e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.84e-06	3.55e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NCOA2—breast cancer	3.84e-06	3.54e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NOS3—breast cancer	3.84e-06	3.54e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—COMT—breast cancer	3.81e-06	3.51e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTP1—breast cancer	3.79e-06	3.49e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NCOA1—breast cancer	3.79e-06	3.49e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMOX1—breast cancer	3.74e-06	3.45e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—STK11—breast cancer	3.73e-06	3.44e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP19A1—breast cancer	3.73e-06	3.44e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ITPR1—breast cancer	3.73e-06	3.44e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—FASN—breast cancer	3.73e-06	3.44e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MED12—breast cancer	3.72e-06	3.43e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—DPYD—breast cancer	3.72e-06	3.43e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—BCHE—breast cancer	3.71e-06	3.42e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAV1—breast cancer	3.67e-06	3.39e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC5A5—breast cancer	3.66e-06	3.38e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALDOA—breast cancer	3.66e-06	3.38e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCB1—breast cancer	3.59e-06	3.31e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NCOA3—breast cancer	3.55e-06	3.28e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CB—breast cancer	3.54e-06	3.27e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC2A1—breast cancer	3.54e-06	3.26e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NQO1—breast cancer	3.54e-06	3.26e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC2A2—breast cancer	3.53e-06	3.25e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TYMS—breast cancer	3.52e-06	3.25e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—breast cancer	3.51e-06	3.24e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.5e-06	3.23e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NCOR1—breast cancer	3.48e-06	3.21e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.48e-06	3.21e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTM1—breast cancer	3.48e-06	3.21e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—COMT—breast cancer	3.47e-06	3.2e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.47e-06	3.2e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CPT1A—breast cancer	3.46e-06	3.19e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCG2—breast cancer	3.46e-06	3.19e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTR—breast cancer	3.46e-06	3.19e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTP1—breast cancer	3.45e-06	3.19e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP3A4—breast cancer	3.45e-06	3.18e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.43e-06	3.17e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMOX1—breast cancer	3.41e-06	3.14e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ITPR1—breast cancer	3.4e-06	3.14e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP1B1—breast cancer	3.39e-06	3.13e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HPGDS—breast cancer	3.39e-06	3.13e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HBA1—breast cancer	3.37e-06	3.11e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CG—breast cancer	3.34e-06	3.08e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GPX1—breast cancer	3.33e-06	3.08e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.33e-06	3.07e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP1A1—breast cancer	3.3e-06	3.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTT1—breast cancer	3.29e-06	3.03e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ACHE—breast cancer	3.29e-06	3.03e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ERCC2—breast cancer	3.27e-06	3.02e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCB1—breast cancer	3.27e-06	3.02e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NCOA1—breast cancer	3.24e-06	2.99e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TYMS—breast cancer	3.21e-06	2.96e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP19A1—breast cancer	3.19e-06	2.94e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—STK11—breast cancer	3.19e-06	2.94e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTM1—breast cancer	3.17e-06	2.93e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NCOR1—breast cancer	3.17e-06	2.93e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.17e-06	2.93e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP17A1—breast cancer	3.11e-06	2.87e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ENO1—breast cancer	3.08e-06	2.84e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS1—breast cancer	3.08e-06	2.84e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—breast cancer	3.08e-06	2.84e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTEN—breast cancer	3.06e-06	2.83e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GPX1—breast cancer	3.04e-06	2.8e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2D6—breast cancer	3.02e-06	2.79e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP1A1—breast cancer	3.01e-06	2.78e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.99e-06	2.76e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ERCC2—breast cancer	2.98e-06	2.75e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—COMT—breast cancer	2.97e-06	2.74e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NCOA2—breast cancer	2.96e-06	2.73e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTP1—breast cancer	2.95e-06	2.72e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CD—breast cancer	2.94e-06	2.71e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMOX1—breast cancer	2.91e-06	2.69e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ITPR1—breast cancer	2.9e-06	2.68e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—breast cancer	2.9e-06	2.68e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—FASN—breast cancer	2.87e-06	2.65e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BCHE—breast cancer	2.86e-06	2.64e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAV1—breast cancer	2.84e-06	2.62e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC5A5—breast cancer	2.83e-06	2.61e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—breast cancer	2.81e-06	2.59e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCB1—breast cancer	2.79e-06	2.58e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NOS3—breast cancer	2.78e-06	2.56e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TYMS—breast cancer	2.74e-06	2.53e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NQO1—breast cancer	2.73e-06	2.52e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC2A1—breast cancer	2.73e-06	2.52e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTM1—breast cancer	2.71e-06	2.5e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.71e-06	2.5e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NCOR1—breast cancer	2.71e-06	2.5e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.71e-06	2.5e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP1B1—breast cancer	2.62e-06	2.42e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GPX1—breast cancer	2.6e-06	2.4e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAV1—breast cancer	2.59e-06	2.39e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CG—breast cancer	2.58e-06	2.38e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP1A1—breast cancer	2.57e-06	2.37e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.57e-06	2.37e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CB—breast cancer	2.56e-06	2.36e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ERCC2—breast cancer	2.55e-06	2.35e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—breast cancer	2.54e-06	2.34e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NCOA1—breast cancer	2.5e-06	2.3e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.47e-06	2.28e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP19A1—breast cancer	2.46e-06	2.27e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—STK11—breast cancer	2.46e-06	2.27e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—breast cancer	2.4e-06	2.21e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CG—breast cancer	2.36e-06	2.17e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—COMT—breast cancer	2.29e-06	2.11e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTP1—breast cancer	2.28e-06	2.1e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CD—breast cancer	2.27e-06	2.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMOX1—breast cancer	2.25e-06	2.07e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—breast cancer	2.24e-06	2.07e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ITPR1—breast cancer	2.24e-06	2.07e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTEN—breast cancer	2.21e-06	2.04e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAV1—breast cancer	2.21e-06	2.04e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CA—breast cancer	2.16e-06	1.99e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCB1—breast cancer	2.16e-06	1.99e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NOS3—breast cancer	2.15e-06	1.98e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TYMS—breast cancer	2.12e-06	1.95e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.11e-06	1.95e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NCOR1—breast cancer	2.09e-06	1.93e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTM1—breast cancer	2.09e-06	1.93e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.09e-06	1.93e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CD—breast cancer	2.07e-06	1.91e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—breast cancer	2.05e-06	1.89e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CG—breast cancer	2.01e-06	1.86e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX1—breast cancer	2e-06	1.85e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP1A1—breast cancer	1.98e-06	1.83e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CB—breast cancer	1.98e-06	1.83e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ERCC2—breast cancer	1.97e-06	1.82e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—breast cancer	1.96e-06	1.81e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NOS3—breast cancer	1.96e-06	1.81e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—breast cancer	1.85e-06	1.71e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CB—breast cancer	1.81e-06	1.67e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—breast cancer	1.79e-06	1.65e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CD—breast cancer	1.77e-06	1.63e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKT1—breast cancer	1.76e-06	1.63e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—breast cancer	1.75e-06	1.61e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTEN—breast cancer	1.71e-06	1.58e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAV1—breast cancer	1.71e-06	1.57e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NOS3—breast cancer	1.67e-06	1.54e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CA—breast cancer	1.56e-06	1.44e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTEN—breast cancer	1.56e-06	1.44e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CG—breast cancer	1.55e-06	1.43e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CB—breast cancer	1.54e-06	1.42e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—breast cancer	1.53e-06	1.41e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CD—breast cancer	1.37e-06	1.26e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—breast cancer	1.35e-06	1.24e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTEN—breast cancer	1.33e-06	1.23e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NOS3—breast cancer	1.29e-06	1.19e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKT1—breast cancer	1.28e-06	1.18e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CA—breast cancer	1.21e-06	1.11e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CB—breast cancer	1.19e-06	1.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—breast cancer	1.18e-06	1.09e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CA—breast cancer	1.1e-06	1.02e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTEN—breast cancer	1.03e-06	9.5e-06	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKT1—breast cancer	9.86e-07	9.1e-06	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CA—breast cancer	9.41e-07	8.68e-06	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKT1—breast cancer	8.99e-07	8.3e-06	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKT1—breast cancer	7.69e-07	7.09e-06	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CA—breast cancer	7.26e-07	6.7e-06	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKT1—breast cancer	5.93e-07	5.47e-06	CbGpPWpGaD
